The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation
Open accessAbstract
Objective This study investigated the predictive value of rises in IgM class antibodies against double stranded DNA (anti-dsDNA) for ensuing relapses in systemic lupus erythematosus (SLE) in comparison with rises in IgG class antibodies. In addition, it was analysed whether rises in IgM class anti-dsDNA were associated with specific clinical manifestations of SLE. Methods Thirty four of a cohort of 72 SLE patients who were positive for IgM class anti-dsDNA at the start of the study or at the time of a relapse were analysed monthly for class specific anti-dsDNA levels during a median observation period of 19.6 months. Disease activity was scored according to the SLE Disease Activity Index. Anti-dsDNA were measured by IgM and IgG class enzyme linked immunosorbent assay (ELISA) and by Farr assay. Results During the study 18 of 34 patients experienced 26 relapses. Twenty two (85%) of the relapses were accompanied by a positive test for IgM class anti-dsDNA by ELISA, 23 (89%) were positive for IgG class anti-dsDNA by ELISA, and 25 (96%) were positive by Farr assay. Patients with rises in IgG class anti-dsDNA by ELISA or in anti-dsDNA by Farr assay had a significantly higher cumulative risk for relapses than patients without those increases (p = 0.04 and p = 0.03, respectively). This was not the case for rises in IgM class anti-dsDNA (p = 0.16). Moreover, a rise in IgM class anti-dsDNA before a relapse was not associated, expressed in terms of odds ratios, with specific clinical manifestations of SLE. Conclusion Relapses of SLE are frequently accompanied by IgM class anti-dsDNA. Rises of IgM class anti-dsDNA, in contrast with rises in IgG class anti-dsDNA, are not a sensitive tool for predicting a relapse and are not associated with specific clinical manifestations of SLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
dsDNA antibodies are among the most commonly detected ANAs in SLE and correlate with disease activity and especially renal involvement.
“As double-stranded DNA (dsDNA) antibodies are among the most commonly detected ANAs in SLE, reported to correlate also with disease activity and especially renal involvement (6-9)”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Autoantibodies to Nuclear Antigens (ANA): Their Immunobiology and Medicine
Tan, E. M. (1982) · Advances in immunology · doi:10.1016/s0065-2776(08)60836-6 · Cited by 961
Hahn, B. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381906 · Cited by 677
Ter Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330505 · Cited by 572
Self-citationPowell, R. J. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.3.157-b · Cited by 343
Petri, M., Genovese, M. C., Engle, E. W., & Hochberg, M. C. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340802 · Cited by 340
Prevention of relapses in systemic lupus erythematosus
Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., & Hermans, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90114-0 · Cited by 290
Self-citationPredictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus.
Swaak, A. J. G., Groenwold, J., & BRONSVELD, W. (1986) · Annals of the Rheumatic Diseases · doi:10.1136/ard.45.5.359 · Cited by 225
Esdaile, J. M., Abrahamowicz, M., Joseph, L., MacKenzie, T. A., Li, Y., & Danoff, D. S. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390304 · Cited by 177
Rothfield, N. F., & Stollar, B. D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105669 · Cited by 172
Okamura, M., Kanayama, Y., Amastu, K., Negoro, N., KOHDA, S., Takeda, T., & Inoue, T. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.1.14 · Cited by 158
Disordered Immunologic Regulation and Autoimmunity
Talal, N. (1976) · Immunological Reviews · doi:10.1111/j.1600-065x.1976.tb01456.x · Cited by 155
Reassessment of the clinical significance of native dna antibodies in systemic lupus erythematosus
Miniter, M. F., Stollar, B. D., & Agnello, V. (1979) · Arthritis & Rheumatism · doi:10.1002/art.1780220903 · Cited by 124
Measurement of anti-DNA antibodies: a reappraisal using five different methods.
Isenberg, D. A., Dudeney, C., Williams, W., Addison, I. E., Charles, S., Clarke, J., & Todd-Pokropek, A. E. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.6.448 · Cited by 110
Sontheimer, R. D., & Gilliam, J. N. (1978) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(78)90158-7 · Cited by 108
Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus.
Pennebaker, J. B., Gilliam, J. N., & Ziff, M. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108892 · Cited by 100
Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus
Tax, W. J. M., Kramers, C., van Bruggen, M. C. J., et al. (1995) · Kidney International · doi:10.1038/ki.1995.336 · Cited by 97
Measurement of anti-double-stranded DNA antibodies in major immunoglobulin classes
Aotsuka, S.-I., Okawa, M., Ikebe, K., & Yokohari, R. (1979) · Journal of Immunological Methods · doi:10.1016/0022-1759(79)90337-5 · Cited by 91
Swaak, T., & Smeenk, R. (1985) · Annals of the Rheumatic Diseases · doi:10.1136/ard.44.4.245 · Cited by 89
Werle, E., Blazek, M., & Fiehn, W. (1992) · Lupus · doi:10.1177/096120339200100606 · Cited by 39
Hylkema, M. N., Huygen, H., Kramers, C., der Wal, T. J. V., de Jong, J., van Bruggen, M. C. J., Swaak, A. J. G., Berden, J. H. M., & Smeenk, R. J. T. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90249-6 · Cited by 37
A comparison of assays used for the detection of antibodies to DNA
Smeenk, R. J. T., Brinkman, K., van den Brink, H. G., & Swaak, T. J. G. (1990) · Clinical Rheumatology · doi:10.1007/bf02205553 · Cited by 33
Relationship of renal histopathology in SLE nephritis to immunoglobulin class of anti-DNA
Clough, J. D., & Valenzuela, R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90169-2 · Cited by 30
Krippner, H., Merle, S., Jörgens, K., et al. (1985) · PubMed · Cited by 15
Standards for ANA and anti-DNA
Feltkamp, T. E. W. (1990) · Clinical Rheumatology · doi:10.1007/bf02205554 · Cited by 14
Disordered immunologic regulation and autoimmunity.
Talal, N. (1978) · PubMed · Cited by 9
Induction of anti-DNA IgG and IgE antibodies in mice
Namboodiri, M. S. A., Nagpal, S., & Sriramarao, P. (1992) · Journal of Autoimmunity · doi:10.1016/0896-8411(92)90161-i · Cited by 5
Flagged first, then by citations
Cited by
Sorted by citations
Classification and definition of major flares in SLE clinical trials
Petri, M., Buyon, J., & Kim, M. (1999) · Lupus · doi:10.1191/096120399680411281 · Cited by 282
Mummert, E., Fritzler, M. J., Sjöwall, C., Bentow, C., & Mahler, M. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.05.014 · Cited by 86
Launay, D., Schmidt, J., Lepers, S., Mirault, T., Lambert, M., Kyndt, X., Reumaux, D., Duhamel, A., Hachulla, E., Hatron, P.-Y., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.03.016 · Cited by 35
Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review.
Orme, M. E., Voreck, A., Aksouh, R., & Schreurs, M. W. J. (2022) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab146 · Cited by 30
Fiegel, F., Buhl, A., Jaekel, H.-P., Werle, E., Schmolke, M., Ollert, M., & Luppa, P. (2010) · Lupus · doi:10.1177/0961203310369681 · Cited by 24
de Leeuw, K., Bungener, L., Roozendaal, C., Bootsma, H., & Stegeman, C. A. (2017) · Rheumatology · doi:10.1093/rheumatology/kew462 · Cited by 24
Self-citationHillebrand, J., Moens, H. B., & Mulder, A. (2013) · Lupus · doi:10.1177/0961203313500368 · Cited by 21
Metadata
- Authors
- Bootsma, H., Spronk, P. E., Borg, E. J. T., Hummel, E. J., de Boer, G., Limburg, P. C., & Kallenberg, C. G. M.
- Affiliations
- University Medical Center Groningen (NL)
- Corresponding author
- Bootsma, Hendrika
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 1997-11
- Volume
- 56
- Issue
- 11
- Pages
- 661-666
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2129852468
- Cited by
- 115
- References
- 27
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 5 · 2015: 2 · 2014: 3 · 2013: 7 · 2012: 4
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annals of the Rheumatic Diseases (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- systemic lupus erythematosus, anti-dsDNA antibodies, recurrence, recurrence prediction, SLE disease activity index, clinical features
- MeSH terms
- Adolescent, Adult, Aged, Antibodies, Antinuclear, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immunoglobulin G, Immunoglobulin M, Lupus Erythematosus, Systemic, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Recurrence, Radioimmunoprecipitation Assay
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
